SLSN 8-K
Solesence, Inc. (SLSN)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On December 18, 2024, the Nanophase Technologies Corporation (the “Company” held its Annual Meeting of Shareholders (the “Annual Meeting”). As of November 22, 2024, the record date for holders of shares of common stock (the “Shares”) entitled to vote at the Annual Meeting, there were 69,994,979 Shares outstanding and entitled to vote at the Annual Meeting. Of the Shares entitled to vote, 54,315,518, or approximately 77.6% of the Shares, were present or represented by proxy at the Annual Meeting, constituting a quorum under the Company’s Certificate of Incorporation. There were two matters presented and voted on at the Annual Meeting. Set forth below is a brief description of each matter voted on at the Annual Meeting and the final voting results with respect to each such matter.
Proposal 1 – Election of two director nominees.
| Nominee | Votes For | Votes Against | Withheld |
| Jess A. Jankowski | 54,280,750 | 0 | 34,768 |
| Mark E. Miller | 54,300,526 | 0 | 14,992 |
The shareholders elected each of the nominees as directors.
Proposal 4 – Ratification of the appointment of RSM US LLP as the Company’s independent registered public accounting firm for 2024.
| Votes For | Votes Against | Abstentions | |
| Votes Cast | 54,297,821 | 13,101 | 4,596 |
The shareholders ratified the appointment of RSM US LLP as the Company’s independent registered public accounting firm for fiscal year 2024.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: December 23, 2024
| NANOPHASE TECHNOLOGIES CORPORATION | |||
| By: | /s/ JESS JANKOWSKI | ||
| Name: Jess Jankowski | |||
| Title: Chief Executive Officer | |||